Ehud Zigmond
Impact in
- Immunology top 1%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
- Phagocytosis and Immune Regulation
- Hepatology top 2%
Papers in
- Immunology 20
- Immune Cell Function and Interaction 12
- Immune cells in cancer 10
- IL-33, ST2, and ILC Pathways 5
- Immunotherapy and Immune Responses 5
- Immune Response and Inflammation 5
-
- Liver Diseases and Immunity 6
- Co-authors
- Steffen Jung (9 shared papers)Chen Varol (15 shared papers)Júlia Farache (4 shared papers)Guy Shakhar (4 shared papers)Zamir Halpern (5 shared papers)Ki-wook Kim (3 shared papers)Metsada Pasmanik‐Chor (5 shared papers)Gilgi Friedlander (2 shared papers)
- Journals
- Immunity (5 papers)Frontiers in Immunology (3 papers)Scientific Reports (2 papers)Liver International (2 papers)Molecular Therapy (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ehud Zigmond
42 papers receiving 3.9k citations
Ehud Zigmond's Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 2.1k
- Hepatology 326
- Neurology 234
- Oncology 598
- Gastroenterology 89
Countries citing papers authored by Ehud Zigmond
This map shows the geographic impact of Ehud Zigmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehud Zigmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehud Zigmond more than expected).
Fields of papers citing papers by Ehud Zigmond
This network shows the impact of papers produced by Ehud Zigmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehud Zigmond. The network helps show where Ehud Zigmond may publish in the future.
Co-authors
The 25 scholars most cited alongside Ehud Zigmond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ly6Chi Monocytes in the Inflamed Colon Give Rise to Proinflammatory Effector Cells and Migratory Antigen-Presenting Cells Hit paper breakdown → | 2012 | 593 |
| 2 | 2014 | 438 | |
| 3 | 2014 | 392 | |
| 4 | 2013 | 370 | |
| 5 | 2016 | 290 | |
| 6 | 2011 | 230 | |
| 7 | 2014 | 209 | |
| 8 | 2010 | 176 | |
| 9 | 2013 | 153 | |
| 10 | 2020 | 116 | |
| 11 | 2013 | 109 | |
| 12 | 2017 | 89 | |
| 13 | 2006 | 85 | |
| 14 | 2008 | 66 | |
| 15 | 2009 | 65 | |
| 16 | 2006 | 58 | |
| 17 | 2011 | 54 | |
| 18 | 2018 | 42 | |
| 19 | 2015 | 42 | |
| 20 | 2017 | 37 |
About Ehud Zigmond
Ehud Zigmond is a scholar working on Immunology, Hepatology, Genetics, Epidemiology and Oncology, having authored 43 papers that have together received 3.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Immune cells in cancer (10 papers), Liver Diseases and Immunity (6 papers), Liver Disease Diagnosis and Treatment (6 papers), IL-33, ST2, and ILC Pathways (5 papers), Immunotherapy and Immune Responses (5 papers), Immune Response and Inflammation (5 papers) and Inflammatory Bowel Disease (4 papers). The work is most often cited by research in Immunology (2.1k citations), Hepatology (326 citations), Neurology (234 citations), Oncology (598 citations) and Gastroenterology (89 citations). Ehud Zigmond has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Steffen Jung, Chen Varol, Júlia Farache, Guy Shakhar, Zamir Halpern, Ki-wook Kim, Metsada Pasmanik‐Chor, Gilgi Friedlander, Eli Brazowski and Oren Shibolet. Their work appears in journals such as Immunity, Frontiers in Immunology, Scientific Reports, Liver International and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.